US Patent 7119106 Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
Patent 7119106 was granted and assigned to Celgene on October, 2006 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7119106 Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
